Combined mean corpuscular hemoglobin, fibrinogen, and albumin (MF-A) is a novel prognostic marker in patients with resectable esophageal squamous cell …

L Liang, F Liu, W Yang, W Yang, L Chen, Y He… - Annals of Surgical …, 2022 - Springer
Background The aim was to systematically select blood markers routinely tested in clinical
settings, which are independently associated with overall survival (OS) and are able to …
被引用次数：4 相关文章

Combined Mean Corpuscular Hemoglobin, Fibrinogen, and Albumin (MF-A) Is a Novel Prognostic Marker in Patients with Resectable Esophageal Squamous Cell …

L Liang, F Liu, W Yang, W Yang, L Chen… - Annals of Surgical …, 2022 - search.proquest.com
Background The aim was to systematically select blood markers routinely tested in clinical
settings, which are independently associated with overall survival (OS) and are able to …

Combined Mean Corpuscular Hemoglobin, Fibrinogen, and Albumin (MF-A) Is a Novel Prognostic Marker in Patients with Resectable Esophageal Squamous Cell …

L Liang, F Liu, W Yang, L Chen, Y He, Z Liu… - Annals of Surgical …, 2022 - europepmc.org
Background The aim was to systematically select blood markers routinely tested in clinical
settings, which are independently associated with overall survival (OS) and are able to …

Combined Mean Corpuscular Hemoglobin, Fibrinogen, and Albumin (MF-A) Is a Novel Prognostic Marker in Patients with Resectable Esophageal Squamous Cell …

L Liang, F Liu, W Yang, W Yang… - Annals of surgical …, 2022 - pubmed.ncbi.nlm.nih.gov
Background The aim was to systematically select blood markers routinely tested in clinical
settings, which are independently associated with overall survival (OS) and are able to …